As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers' plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote recei ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against PubMatic, Inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [1][3]. Group 1: Allegations Against PubMatic - The complaint alleges that PubMatic and its executives made false or misleading statements and failed to disclose significant issues, including a top DSP buyer shifting clients to a new platform, leading to reduced ad spend and revenue [3]. - The company's positive statements regarding its business operations and prospects were deemed materially misleading and lacked a reasonable basis due to these undisclosed issues [3]. Group 2: Financial Impact - On August 11, 2025, PubMatic's CFO disclosed a reduction in ad spend from a top DSP partner, which was a significant factor affecting the company's outlook [4]. - Following this announcement, PubMatic's stock price dropped by $2.23, or 21.1%, closing at $8.34 per share on August 12, 2025, amid unusually high trading volume [4]. Group 3: Legal Proceedings - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against PubMatic is October 20, 2025 [1]. - Any member of the putative class can move the court to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Quanex Building Products Corporation due to alleged violations of federal securities laws, particularly concerning misleading statements about the company's operational issues and financial performance [1][3]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Quanex between December 12, 2024, and September 5, 2025, to discuss their legal options [1]. - The firm has set a deadline of November 18, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Quanex [1]. Allegations Against Quanex - The complaint alleges that Quanex and its executives made false or misleading statements regarding the maintenance of tooling and equipment at the Tyman Mexico facility, which were significantly underinvested [3]. - It is claimed that the conditions of the tooling and equipment had degraded to near catastrophic levels, leading to significant costs and delays in expected benefits from the Tyman integration [3]. Financial Performance - On September 4, 2025, Quanex reported a diluted EPS of ($6.04), a significant decline from $0.77 in the prior year period, and an adjusted EBITDA of $70.30 [4]. - The company acknowledged ongoing operational issues related to the Tyman business in Mexico, which negatively impacted financial results more than anticipated during the third quarter of 2025 [4]. Earnings Call Insights - During the earnings call on September 5, 2025, CEO George Wilson highlighted that operational challenges in the Tyman facility negatively impacted EBITDA by nearly $5 million in the third quarter [5]. - Wilson noted that the issues were identified midyear and that the systems for anticipating and planning tooling repairs were severely deficient, indicating a state of underinvestment [5]. Stock Market Reaction - Following the earnings announcement, Quanex's stock price fell by $2.73, or 13.1%, closing at $18.18 per share on September 5, 2025, with unusually high trading volume [5]. - The stock continued to decline, dropping an additional $1.98, or 10.9%, to close at $16.20 per share on September 8, 2025, also on unusually heavy trading volume [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you suffered losses in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983- 9330Â (Ext. 1310). [You may also click here for additional information] , /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national ...

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) between January 16, 2025, and September 12, 2025, inclusive. You are hereby notified that the class action lawsuit Marco Munguia v. aTyr Pharma, Inc., et al. (Case No. 3:25-cv-02681) has been commenced in the United States District Court for the Southern District ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against V.F. Corporation (VFC) due to alleged violations of federal securities laws, particularly concerning misleading statements about the company's turnaround plans and the performance of the Vans brand [4][6]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses in VFC between October 30, 2023, and May 20, 2025, to discuss their legal options [1][4]. - A federal securities class action has been filed against VFC, with a deadline of November 12, 2025, for investors to seek the role of lead plaintiff [4][8]. Group 2: Allegations Against VFC - The complaint alleges that VFC and its executives made false or misleading statements regarding the company's turnaround plans, particularly the need for significant reset actions to return the Vans brand to growth [6]. - The company's stock price fell approximately 15.8% in one day, from $14.43 per share on May 20, 2025, to $12.15 per share on May 21, 2025, following the disclosure of disappointing financial results [7]. Group 3: Financial Performance - VFC reported a significant decline in Vans' growth trajectory, with losses worsening from 8% in the previous quarter to 20% in the fourth quarter of fiscal 2025 [7]. - The company attributed its poor performance to deliberate actions taken to eliminate unprofitable businesses, which were not previously disclosed to investors [7].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you suffered losses in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a lea ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) securities between February 5, 2025 and July 23, 2025 (the “Class Period”) have until December 2, 2025 to seek appointment as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The filed complaint alleges that Molina Healthcare and certain executives violated the Securities Exchange Act of 1934 by making materia ...

This story was originally published on Payments Dive. To receive daily news and insights, subscribe to our free daily Payments Dive newsletter. A South Florida police pension fund and a European-based investment firm want to serve as lead plaintiff in a class-action shareholder lawsuit against Fiserv over the payment behemoth’s Clover unit. The motions last month were filed by the pension fund for police officers in Hollywood, Florida, along with a competing motion from Ethenea Independent Investors SA of ...

Oct 6, 2025 1:03 PM Eastern Daylight Time Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212- 983-9330 (Ext. 1310). Share [You may also click here for additional information] Faruqi ...